![](https://cdn.sanity.io/images/0vv8moc6/curetoday/3099928b4c4f648b6f5d2bc7989bf56a918f3edf-4500x3000.jpg?fit=crop&auto=format)
Opdivo Plus Cometyx Safe, Effective in Advanced Renal Cell Carcinoma
Among patients with previously untreated, advanced renal cell carcinoma (RCC), treatment with Opdivo (nivolumab) plus Cometyx (cabozantinib) resulted in long-term efficacy and manageable safety versus treatment with the standard of care, Sutent (sunitinib …